Krystal Biotech, Inc. is seeking a Regional Gene Therapy Consultant (RGTC) to lead the launch of Vyjuvek for dystrophic epidermolysis bullosa (DEB) in their territory.
The role emphasizes patient-centric sales, accountability, and collaboration with internal teams to ensure patient access and education. TheRGTC will drive a comprehensive territory plan, build strong relationships with dermatology specialists and key stakeholders, and represent the voice of the customer in Krystal’s commercial
#J-18808-LjbffrRegional Gene Therapy Consultant for DEB Launch in seattle at Unknown Company
This position is listed as full time and onsite.